Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Ascentage Pharma’s U.S. IPO will support clinical testing of its two lead drugs, small molecules in development for advanced ...

Criticism over how the Chinese government buys drugs for its public health care system has ignited frustration over the ...

Top doctors raised concerns about domestically made drugs, saying Beijing’s effort to lower costs is sacrificing quality.

Adding camrelizumab and rivoceranib to TACE improved PFS in patients with unresectable HCC in a phase 2 trial.

In an effort to safeguard fair market competition and protect consumer interests, the State Council's anti-monopoly ...

Indian generic drugmaker Dr Reddy's Laboratories on Thursday said it was optimistic about the Donald Trump administration, as it believes the country would have an edge amid tensions between the ...

Zai Lab (ZLAB) announced that China’s National Medical Products Administration, NMPA, has accepted the New Drug Application, NDA, for KarXT for ...

Shares of Waters Corp . (NYSE: NYSE: WAT) tumbled 5% today, as the U.S. Commerce Department announced new export controls on biotechnology equipment, citing national security concerns. The new ...

The aPKCi inhibitor platform is a novel, potential high-potency, specific, drug candidate with applications in oncology ...

Zai Lab (NASDAQ:ZLAB) announced Wednesday it would seek marketing approval for its cervical cancer therapy Tivdak (tisotumab ...

A recently unsealed application for a federal wiretap offers glimpses of the serpentine path of a major drug investigation.